Nicotinamide and pyruvate in glaucoma: a neuroprotection trial design
The paper describes a long-term randomised trial of metabolic neuroprotection in open-angle glaucoma.
doi: 10.1016/j.ogla.2025.12.008Latest reviews
One study, its results and limitations.
Ranibizumab versus laser for diabetic macular oedema
A meta-analysis compared intravitreal ranibizumab with laser photocoagulation for diabetic macular oedema.
doi: 10.3389/fendo.2025.1608456Age-related choroidal atrophy and its distinction from AMD
The review organised multimodal-imaging features of age-related choroidal atrophy.
doi: 10.1016/j.survophthal.2025.12.005Cost effectiveness of anti-VEGF treatment for wet AMD
A systematic review compared economic models for drugs used in neovascular AMD.
doi: 10.1016/j.vhri.2025.101542Aflibercept biosimilars for retinal disease
A meta-analysis compared aflibercept biosimilars with reference aflibercept in neovascular AMD and diabetic macular oedema.
doi: 10.1016/j.survophthal.2025.11.007Aflibercept 8 mg for DME: 96-week PHOTON results
PHOTON compared 8 mg aflibercept at extended intervals with standard 2 mg dosing every eight weeks.
doi: 10.1016/j.ophtha.2025.10.028Red-light therapy combined with orthokeratology: six-month data
A small study compared orthokeratology alone with the addition of repeated low-level red-light therapy.
doi: 10.1080/09286586.2025.2580682Red-light therapy for myopia: a multi-ethnic pilot trial
A pilot trial compared repeated low-level red light with single-vision spectacles in schoolchildren.
doi: 10.1080/09286586.2025.2500020Orthokeratology optic-zone diameter and myopia control
The study compared aspheric orthokeratology lenses with different back optic-zone diameters.
doi: 10.1016/j.clae.2025.102491The economic burden of myopia management
A systematic review collected costs of correction, monitoring, complications and myopia-control interventions.
doi: 10.7189/jogh.15.04322